Clinical Practice
BPD Prescribing: A PMHNP Reality Check for 2026
The APA's 2024 borderline personality guideline says no drug treats the core illness. Here is what PMHNPs should actually prescribe and avoid.
Tagged
off-label prescribing
Real talk about psychopharmacology, clinical confidence, and building a practice you love — from Lindsay and the Fellowship faculty.
More Articles
Clinical Practice
Pramipexole for Treatment-Resistant Depression: What PMHNPs Should Know
The PAX-D trial showed pramipexole reduced treatment-resistant depression symptoms by week 12. Here's what PMHNPs need to know about dosing, monitoring, and clinical use.